Table 3.
Fluid status before CRRT | Fluid status 3 days later | Total death, n (%) | ||||
---|---|---|---|---|---|---|
Type 1 | Type 2 | Type 3 | Type 4 | |||
Type 1 | Cumulative fluid balance, mL | 1,664 ± 1,971 | 3,832 ± 4,291 | 2,626 ± 3,732 | 870 | |
Death, n (%) | 1/10 (10%) | 1/3 (33.3%) | 2/3 (66.6%) | 0/1 (0%) | 4/17 (23.5%) | |
Type 2 | Cumulative fluid balance, mL | 1,566 | 2,365 ± 2,140 | 3,935 ± 2,130 | 5,974 ± 3,144 | |
Death, n (%) | 0/1 (0%) | 1/4 (25%) | 0/2 (0%) | 2/4 (50%) | 3/11 (27.3%) | |
Type 3 | Cumulative fluid balance, mL | 571 | - | 1,601 ± 1,147 | 3,242 ± 3,296 | |
Death, n (%) | 0/1 (0%) | 0 | 1/3 (33.3%) | 2/5 (40%) | 3/9 (33.3%) | |
Type 4 | Cumulative fluid balance, mL | −1,380 ± 3,308 | −1,159 ± 3,394 | 2,461 ± 2,844 | 2,613 ± 3,962 | |
Death, n (%) | 3/4 (75%) | 1/5 (20%) | 1/4 (25%) | 14/20 (70%) | 19/33 (57.6%) | |
Total death, n (%) | 4/16 (25%) | 3/12 (25%) | 4/12 (33.3%) | 18/30 (60%) | 29/70 (41.4%) |
Fluid status: type 1, no overhydration and B-type natriuretic peptide (BNP) normal; type 2, no overhydration but BNP abnormal; type 3, overhydration but BNP normal; type 4, overhydration and BNP abnormal. CRRT, continuous renal replacement therapy.